162 related articles for article (PubMed ID: 2814339)
1. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies.
Heptner G; Domschke S; Domschke W
Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
3. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
Staab HJ
Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
[No Abstract] [Full Text] [Related]
4. The value of CA 19-9 in gastric and colorectal carcinoma.
Safi F; Bittner R; Roscher R; Kübel R; Beger HG
Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
[TBL] [Abstract][Full Text] [Related]
6. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma.
Satake K; Kanazawa G; Kho I; Chung YS; Umeyama K
J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
[TBL] [Abstract][Full Text] [Related]
8. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
Tappero G; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies.
Kornek GV; Depisch D; Rosen HR; Temsch EM; Scheithauer W
J Cancer Res Clin Oncol; 1992; 118(4):318-20. PubMed ID: 1374412
[TBL] [Abstract][Full Text] [Related]
10. Serum values of CA72.4 in patients with gastrointestinal system tumors comparison with CEA and CA 19.9.
Yasasever V; Sengün Z; Saydan N; Onat H; Dalay N
Eur J Gynaecol Oncol; 1992; 13(5):403-8. PubMed ID: 1486919
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
13. Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer.
Talbot RW; Nagorney DM; Pemberton JH; Wieand HS; Ritts RE
Cancer Res; 1989 Feb; 49(3):542-3. PubMed ID: 2910474
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
Kuusela P; Haglund C; Roberts PJ; Jalanko H
Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
[TBL] [Abstract][Full Text] [Related]
15. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
[TBL] [Abstract][Full Text] [Related]
16. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
[TBL] [Abstract][Full Text] [Related]
17. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen (CEA): a comparison of the Farr and Z-gel methods for CEA detection in benign and malignant diseases.
Band P; Hyde H; Feldstein M; McPherson I; Patwardhan V
Eur J Cancer (1965); 1973 Aug; 9(8):597-602. PubMed ID: 4788847
[No Abstract] [Full Text] [Related]
19. Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers.
Andriulli A; Gindro T; Piantino P; Farini R; Cavallini G; Piazzi L; Naccarato R; Dobrilla G; Verme G; Scuro LA
Digestion; 1986; 33(1):26-33. PubMed ID: 3940235
[TBL] [Abstract][Full Text] [Related]
20. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]